Prostate cancer Archives -

Targeting COVID-19 and cancer with immunotherapy advancements

News/ News/ News/ Oncology/ R&D

RhoVac pummelled as lead cancer vaccine fails study

Phil Taylor cancer vaccine, immuno-oncology, metastatic, Oncology, Prostate cancer, RhoVac 0 Comment

Shares in Swedish biotech RhoVac were down 94% in mid-morning trading today after the company revealed a phase

RhoVac pummelled as lead cancer vaccine fails study

https://pharmaphorum.com/news/rhovac-pummelled-as-lead-cancer-vaccine-fails-study/

Market Access/ News/ News

UK grants early access to Novartis’ prostate cancer radioligand

Phil Taylor Advanced Accelerator Applications, Early Access to Medicines Scheme, MHRA, Novartis, Pluvicto, Prostate cancer, Radiopharmaceutical, UK 0 Comment

The UK regulator has said eligible patients with prostate cancer will get early access to a radioligand therapy

UK grants early access to Novartis’ prostate cancer radioligand

https://pharmaphorum.com/news/uk-grants-early-access-to-novartis-prostate-cancer-radioligand/

News/ News/ Oncology

Novartis gets first OK for radioligand Pluvicto in prostate cancer

Phil Taylor Novartis, Oncology, Pluvicto, Prostate cancer, Radiopharmaceutical, regulatory approval 0 Comment

Novartis has been steadily investing in radiopharmaceuticals over the last few years, and one of those deals has

Novartis gets first OK for radioligand Pluvicto in prostate cancer

https://pharmaphorum.com/news/novartis-gets-first-ok-for-radioligand-pluvicto-in-prostate-cancer/

News/ News/ Oncology

Merck trial of Keytruda, Lynparza combo in prostate cancer fails

Phil Taylor AstraZeneca, immuno-oncology, Keytruda, Lynparza, Merck & Co, Oncology, Prostate cancer 0 Comment

Merck & Co’s two powerhouse oncology drugs – Keytruda and Lynparza – have failed to show efficacy when

Merck trial of Keytruda, Lynparza combo in prostate cancer fails

https://pharmaphorum.com/news/merck-trial-of-keytruda-lynparza-combo-in-prostate-cancer-fail/

News/ News/ Oncology

Chasing rivals, Bayer files Nubeqa for new prostate cancer use

Phil Taylor Bayer, Nubeqa, Oncology, Orion, Prostate cancer, regulatory 0 Comment

Bayer has filed for approval to extend the use of its prostate cancer therapy Nubeqa as it tries

Chasing rivals, Bayer files Nubeqa for new prostate cancer use

https://pharmaphorum.com/news/chasing-rivals-bayer-files-nubeqa-for-new-prostate-cancer-use/

News/ News/ Sales and Marketing

Bayer triples sales forecast for prostate cancer drug Nubeqa

Phil Taylor Bayer, Erleada, Financial, Nubeqa, Prostate cancer, Xtandi 0 Comment

Bayer now says it expects to make €3 billion in sales for its prostate cancer treatment Nubeqa, up

Bayer triples sales forecast for prostate cancer drug Nubeqa

https://pharmaphorum.com/news/bayer-triples-sales-forecast-for-prostate-cancer-drug-nubeqa/

Market Access/ News/ News

After a Scottish aye, NICE says no to Lynparza for prostate cancer

Phil Taylor AstraZeneca, HEOR, Lynparza, NICE, PARP inhibitor, Prostate cancer 0 Comment

AstraZeneca’s PARP inhibitor Lynparza should not be made available routinely on the NHS n England and Wales as

After a Scottish aye, NICE says no to Lynparza for prostate cancer

https://pharmaphorum.com/news/after-a-scottish-aye-nice-says-no-to-lynparza-for-prostate-cancer/

News/ News/ Oncology

Trial closes gap between Bayer’s Nubeqa and rivals in prostate cancer

Phil Taylor Astellas, Bayer, Erleada, Johnson & Johnson, Nubeqa, Oncology, Pfizer, Prostate cancer, Xtandi 0 Comment

Bayer’s Nubeqa is making headway as a treatment for castration-resistant prostate cancer (CRPC), but could be on track

Trial closes gap between Bayer’s Nubeqa and rivals in prostate cancer

https://pharmaphorum.com/news/trial-narrows-gap-between-bayers-nubeqa-and-rivals-in-prostate-cancer/

Digital/ News/ News

Helix web tool guides prostate cancer genetic testing

Phil Taylor clinical decision-making, digital, digital health, Oncology, Prostate cancer 0 Comment

A web-based digital tool called Helix could help clinicians identify patients with prostate cancer who would benefit from

Helix web tool guides prostate cancer genetic testing

https://pharmaphorum.com/news/helix-webtool-guides-prostate-cancer-genetic-testing/

Trending

Prostate cancer

Login